002773 康弘药业
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额805,0181,218,411925,153494,114273,315
投资活动产生之现金流量净额(2,175,915)6,616(215,553)(803,136)(583,965)
筹资活动产生之现金流量净额(349,792)(130,498)(73,851)(78,839)1,357,173
汇率变动对现金及现金等价物的影响(304)(212)987(869)(2,599)
现金及现金等价物净增加/(减少)(1,720,993)1,094,318636,736(388,730)1,043,925
期初现金及现金等价物余额4,669,9943,575,6762,938,9403,327,6702,283,745
期末现金及现金等价物余额2,949,0014,669,9943,575,6762,938,9403,327,670